Furthermore, a recent study showed that elevated serum levels of the extracellular portion of AXL, which can enter the circulation after proteolytic cleavage by the proteases ADAM10 and ADAM17, correlates with disease progression and poor survival in cutaneous MM (7). This evidence concerns the gene AXL and Miyoshi myopathy.